Report ID : AMR1004887 | Industries : Healthcare | Published On :December 2023 | Page Count : 232
Global Antiplatelet Drugs Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Antiplatelet Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to Recent Energy Crisis
4.2.5 Cumulative Impact due to Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply & Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Antiplatelet Drugs Market, By Drug
5.1 Y-o-Y Growth Comparison, By Drug
5.2 Global Antiplatelet Drugs Market Share Analysis, By Drug
5.3 Global Antiplatelet Drugs Market Size and Forecast, By Drug
5.3.1 Aspirin
5.3.2 Clopidogrel
5.3.3 Ticagrelor
5.3.4 Prasugrel
5.3.5 Others
6 Global Antiplatelet Drugs Market, By Indication
6.1 Y-o-Y Growth Comparison, By Indication
6.2 Global Antiplatelet Drugs Market Share Analysis, By Indication
6.3 Global Antiplatelet Drugs Market Size and Forecast, By Indication
6.3.1 Myocardial Infraction
6.3.2 Percutaneous Coronary Interventions
6.3.3 Arterial Thrombosis
6.3.4 Others
7 Global Antiplatelet Drugs Market, By Route of Administration
7.1 Y-o-Y Growth Comparison, By Route of Administration
7.2 Global Antiplatelet Drugs Market Share Analysis, By Route of Administration
7.3 Global Antiplatelet Drugs Market Size and Forecast, By Route of Administration
7.3.1 Oral
7.3.2 Injectable
8 Global Antiplatelet Drugs Market, By End-Users
8.1 Y-o-Y Growth Comparison, By End-Users
8.2 Global Antiplatelet Drugs Market Share Analysis, By End-Users
8.3 Global Antiplatelet Drugs Market Size and Forecast, By End-Users
8.3.1 Hospitals
8.3.2 Specialty Clinics
8.3.3 Homecare
8.3.4 Others
9 Global Antiplatelet Drugs Market, By Distribution Channel
9.1 Y-o-Y Growth Comparison, By Distribution Channel
9.2 Global Antiplatelet Drugs Market Share Analysis, By Distribution Channel
9.3 Global Antiplatelet Drugs Market Size and Forecast, By Distribution Channel
9.3.1 Hospital Pharmacy
9.3.2 Retail Pharmacy
9.3.3 Others
10 Global Antiplatelet Drugs Market, By Region
10.1 Global Antiplatelet Drugs Market Share Analysis, By Region
10.2 Global Antiplatelet Drugs Market Size and Forecast, By Region
10.3 Global Antiplatelet Drugs Market Trends and Forecast, By Region
11 North America Antiplatelet Drugs Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 North America Antiplatelet Drugs Market Size and Forecast, By Drug
11.3 North America Antiplatelet Drugs Market Size and Forecast, By Indication
11.4 North America Antiplatelet Drugs Market Size and Forecast, By Route of Administration
11.5 North America Antiplatelet Drugs Market Size and Forecast, By End-Users
11.6 North America Antiplatelet Drugs Market Size and Forecast, By Distribution Channel
11.7 North America Antiplatelet Drugs Market Size and Forecast, By Country
11.7.1 U.S.
11.7.1.1 Market Size and Forecast, By Drug
11.7.1.2 Market Size and Forecast, By Indication
11.7.1.3 Market Size and Forecast, By Route of Administration
11.7.1.4 Market Size and Forecast, By End-Users
11.7.1.5 Market Size and Forecast, By Distribution Channel
11.7.2 Canada
11.7.2.1 Market Size and Forecast, By Drug
11.7.2.2 Market Size and Forecast, By Indication
11.7.2.3 Market Size and Forecast, By Route of Administration
11.7.2.4 Market Size and Forecast, By End-Users
11.7.2.5 Market Size and Forecast, By Distribution Channel
11.7.3 Mexico
11.7.3.1 Market Size and Forecast, By Drug
11.7.3.2 Market Size and Forecast, By Indication
11.7.3.3 Market Size and Forecast, By Route of Administration
11.7.3.4 Market Size and Forecast, By End-Users
11.7.3.5 Market Size and Forecast, By Distribution Channel
12 Europe Antiplatelet Drugs Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Europe Antiplatelet Drugs Market Size and Forecast, By Drug
12.3 Europe Antiplatelet Drugs Market Size and Forecast, By Indication
12.4 Europe Antiplatelet Drugs Market Size and Forecast, By Route of Administration
12.5 Europe Antiplatelet Drugs Market Size and Forecast, By End-Users
12.6 Europe Antiplatelet Drugs Market Size and Forecast, By Distribution Channel
12.7 Europe Antiplatelet Drugs Market Size and Forecast, By Country
12.7.1 Germany
12.7.1.1 Market Size and Forecast, By Drug
12.7.1.2 Market Size and Forecast, By Indication
12.7.1.3 Market Size and Forecast, By Route of Administration
12.7.1.4 Market Size and Forecast, By End-Users
12.7.1.5 Market Size and Forecast, By Distribution Channel
12.7.2 France
12.7.2.1 Market Size and Forecast, By Drug
12.7.2.2 Market Size and Forecast, By Indication
12.7.2.3 Market Size and Forecast, By Route of Administration
12.7.2.4 Market Size and Forecast, By End-Users
12.7.2.5 Market Size and Forecast, By Distribution Channel
12.7.3 UK
12.7.3.1 Market Size and Forecast, By Drug
12.7.3.2 Market Size and Forecast, By Indication
12.7.3.3 Market Size and Forecast, By Route of Administration
12.7.3.4 Market Size and Forecast, By End-Users
12.7.3.5 Market Size and Forecast, By Distribution Channel
12.7.4 Russia
12.7.4.1 Market Size and Forecast, By Drug
12.7.4.2 Market Size and Forecast, By Indication
12.7.4.3 Market Size and Forecast, By Route of Administration
12.7.4.4 Market Size and Forecast, By End-Users
12.7.4.5 Market Size and Forecast, By Distribution Channel
12.7.5 Italy
12.7.5.1 Market Size and Forecast, By Drug
12.7.5.2 Market Size and Forecast, By Indication
12.7.5.3 Market Size and Forecast, By Route of Administration
12.7.5.4 Market Size and Forecast, By End-Users
12.7.5.5 Market Size and Forecast, By Distribution Channel
12.7.6 Spain
12.7.6.1 Market Size and Forecast, By Drug
12.7.6.2 Market Size and Forecast, By Indication
12.7.6.3 Market Size and Forecast, By Route of Administration
12.7.6.4 Market Size and Forecast, By End-Users
12.7.6.5 Market Size and Forecast, By Distribution Channel
12.7.7 Rest of Europe
12.7.7.1 Market Size and Forecast, By Drug
12.7.7.2 Market Size and Forecast, By Indication
12.7.7.3 Market Size and Forecast, By Route of Administration
12.7.7.4 Market Size and Forecast, By End-Users
12.7.7.5 Market Size and Forecast, By Distribution Channel
13 Asia Pacific Antiplatelet Drugs Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Asia Pacific Antiplatelet Drugs Market Size and Forecast, By Drug
13.3 Asia Pacific Antiplatelet Drugs Market Size and Forecast, By Indication
13.4 Asia Pacific Antiplatelet Drugs Market Size and Forecast, By Route of Administration
13.5 Asia Pacific Antiplatelet Drugs Market Size and Forecast, By End-Users
13.6 Asia Pacific Antiplatelet Drugs Market Size and Forecast, By Distribution Channel
13.7 Asia Pacific Antiplatelet Drugs Market Size and Forecast, By Country
13.7.1 China
13.7.1.1 Market Size and Forecast, By Drug
13.7.1.2 Market Size and Forecast, By Indication
13.7.1.3 Market Size and Forecast, By Route of Administration
13.7.1.4 Market Size and Forecast, By End-Users
13.7.1.5 Market Size and Forecast, By Distribution Channel
13.7.2 Japan
13.7.2.1 Market Size and Forecast, By Drug
13.7.2.2 Market Size and Forecast, By Indication
13.7.2.3 Market Size and Forecast, By Route of Administration
13.7.2.4 Market Size and Forecast, By End-Users
13.7.2.5 Market Size and Forecast, By Distribution Channel
13.7.3 India
13.7.3.1 Market Size and Forecast, By Drug
13.7.3.2 Market Size and Forecast, By Indication
13.7.3.3 Market Size and Forecast, By Route of Administration
13.7.3.4 Market Size and Forecast, By End-Users
13.7.3.5 Market Size and Forecast, By Distribution Channel
13.7.4 South Korea
13.7.4.1 Market Size and Forecast, By Drug
13.7.4.2 Market Size and Forecast, By Indication
13.7.4.3 Market Size and Forecast, By Route of Administration
13.7.4.4 Market Size and Forecast, By End-Users
13.7.4.5 Market Size and Forecast, By Distribution Channel
13.7.5 Australia
13.7.5.1 Market Size and Forecast, By Drug
13.7.5.2 Market Size and Forecast, By Indication
13.7.5.3 Market Size and Forecast, By Route of Administration
13.7.5.4 Market Size and Forecast, By End-Users
13.7.5.5 Market Size and Forecast, By Distribution Channel
13.7.6 New Zealand
13.7.6.1 Market Size and Forecast, By Drug
13.7.6.2 Market Size and Forecast, By Indication
13.7.6.3 Market Size and Forecast, By Route of Administration
13.7.6.4 Market Size and Forecast, By End-Users
13.7.6.5 Market Size and Forecast, By Distribution Channel
13.7.7 Singapore
13.7.7.1 Market Size and Forecast, By Drug
13.7.7.2 Market Size and Forecast, By Indication
13.7.7.3 Market Size and Forecast, By Route of Administration
13.7.7.4 Market Size and Forecast, By End-Users
13.7.7.5 Market Size and Forecast, By Distribution Channel
13.7.8 Malaysia
13.7.8.1 Market Size and Forecast, By Drug
13.7.8.2 Market Size and Forecast, By Indication
13.7.8.3 Market Size and Forecast, By Route of Administration
13.7.8.4 Market Size and Forecast, By End-Users
13.7.8.5 Market Size and Forecast, By Distribution Channel
13.7.9 Rest of Asia
13.7.9.1 Market Size and Forecast, By Drug
13.7.9.2 Market Size and Forecast, By Indication
13.7.9.3 Market Size and Forecast, By Route of Administration
13.7.9.4 Market Size and Forecast, By End-Users
13.7.9.5 Market Size and Forecast, By Distribution Channel
14 Latin America Antiplatelet Drugs Market Analysis and Forecast (2023-2030)
14.1 Introduction
14.2 Latin America Antiplatelet Drugs Market Size and Forecast, By Drug
14.3 Latin America Antiplatelet Drugs Market Size and Forecast, By Indication
14.4 Latin America Antiplatelet Drugs Market Size and Forecast, By Route of Administration
14.5 Latin America Antiplatelet Drugs Market Size and Forecast, By End-Users
14.6 Latin America Antiplatelet Drugs Market Size and Forecast, By Distribution Channel
14.7 Latin America Antiplatelet Drugs Market Size and Forecast, By Country
14.7.1 Brazil
14.7.1.1 Market Size and Forecast, By Drug
14.7.1.2 Market Size and Forecast, By Indication
14.7.1.3 Market Size and Forecast, By Route of Administration
14.7.1.4 Market Size and Forecast, By End-Users
14.7.1.5 Market Size and Forecast, By Distribution Channel
14.7.2 Argentina
14.7.2.1 Market Size and Forecast, By Drug
14.7.2.2 Market Size and Forecast, By Indication
14.7.2.3 Market Size and Forecast, By Route of Administration
14.7.2.4 Market Size and Forecast, By End-Users
14.7.2.5 Market Size and Forecast, By Distribution Channel
14.7.3 Colombia
14.7.3.1 Market Size and Forecast, By Drug
14.7.3.2 Market Size and Forecast, By Indication
14.7.3.3 Market Size and Forecast, By Route of Administration
14.7.3.4 Market Size and Forecast, By End-Users
14.7.3.5 Market Size and Forecast, By Distribution Channel
14.7.4 Peru
14.7.4.1 Market Size and Forecast, By Drug
14.7.4.2 Market Size and Forecast, By Indication
14.7.4.3 Market Size and Forecast, By Route of Administration
14.7.4.4 Market Size and Forecast, By End-Users
14.7.4.5 Market Size and Forecast, By Distribution Channel
14.7.5 Chile
14.7.5.1 Market Size and Forecast, By Drug
14.7.5.2 Market Size and Forecast, By Indication
14.7.5.3 Market Size and Forecast, By Route of Administration
14.7.5.4 Market Size and Forecast, By End-Users
14.7.5.5 Market Size and Forecast, By Distribution Channel
14.7.6 Venezuela
14.7.6.1 Market Size and Forecast, By Drug
14.7.6.2 Market Size and Forecast, By Indication
14.7.6.3 Market Size and Forecast, By Route of Administration
14.7.6.4 Market Size and Forecast, By End-Users
14.7.6.5 Market Size and Forecast, By Distribution Channel
14.7.7 Rest of Latin America
14.7.7.1 Market Size and Forecast, By Drug
14.7.7.2 Market Size and Forecast, By Indication
14.7.7.3 Market Size and Forecast, By Route of Administration
14.7.7.4 Market Size and Forecast, By End-Users
14.7.7.5 Market Size and Forecast, By Distribution Channel
15 Middle East Antiplatelet Drugs Market Analysis and Forecast (2023-2030)
15.1 Introduction
15.2 Middle East Antiplatelet Drugs Market Size and Forecast, By Drug
15.3 Middle East Antiplatelet Drugs Market Size and Forecast, By Indication
15.4 Middle East Antiplatelet Drugs Market Size and Forecast, By Route of Administration
15.5 Middle East Antiplatelet Drugs Market Size and Forecast, By End-Users
15.6 Middle East Antiplatelet Drugs Market Size and Forecast, By Distribution Channel
15.7 Middle East Antiplatelet Drugs Market Size and Forecast, By Country
15.7.1 Saudi Arabia
15.7.1.1 Market Size and Forecast, By Drug
15.7.1.2 Market Size and Forecast, By Indication
15.7.1.3 Market Size and Forecast, By Route of Administration
15.7.1.4 Market Size and Forecast, By End-Users
15.7.1.5 Market Size and Forecast, By Distribution Channel
15.7.2 UAE
15.7.2.1 Market Size and Forecast, By Drug
15.7.2.2 Market Size and Forecast, By Indication
15.7.2.3 Market Size and Forecast, By Route of Administration
15.7.2.4 Market Size and Forecast, By End-Users
15.7.2.5 Market Size and Forecast, By Distribution Channel
15.7.3 Egypt
15.7.3.1 Market Size and Forecast, By Drug
15.7.3.2 Market Size and Forecast, By Indication
15.7.3.3 Market Size and Forecast, By Route of Administration
15.7.3.4 Market Size and Forecast, By End-Users
15.7.3.5 Market Size and Forecast, By Distribution Channel
15.7.4 Kuwait
15.7.4.1 Market Size and Forecast, By Drug
15.7.4.2 Market Size and Forecast, By Indication
15.7.4.3 Market Size and Forecast, By Route of Administration
15.7.4.4 Market Size and Forecast, By End-Users
15.7.4.5 Market Size and Forecast, By Distribution Channel
15.7.5 South Africa
15.7.5.1 Market Size and Forecast, By Drug
15.7.5.2 Market Size and Forecast, By Indication
15.7.5.3 Market Size and Forecast, By Route of Administration
15.7.5.4 Market Size and Forecast, By End-Users
15.7.5.5 Market Size and Forecast, By Distribution Channel
15.7.6 Rest of Middle East & Africa
15.7.6.1 Market Size and Forecast, By Drug
15.7.6.2 Market Size and Forecast, By Indication
15.7.6.3 Market Size and Forecast, By Route of Administration
15.7.6.4 Market Size and Forecast, By End-Users
15.7.6.5 Market Size and Forecast, By Distribution Channel
16 Competitive Analysis
16.1 Competition Dashboard
16.2 Market share Analysis of Top Vendors
16.3 Key Development Strategies
17 Company Profiles
17.1 Boehringer Ingelheim International GmbH. (Germany)
17.1.2 Offerings
17.1.3 Key Financials
17.1.4 Business Segment & Geographic Overview
17.1.5 Key Market Developments
17.1.6 Key Strategies
17.2 Bayer AG (Germany)
17.2.1 Overview
17.2.2 Offerings
17.2.3 Key Financials
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
17.3 GlaxoSmithKline plc (U.K.)
17.3.1 Overview
17.3.2 Offerings
17.3.3 Key Financials
17.3.4 Business Segment & Geographic Overview
17.3.5 Key Market Developments
17.3.6 Key Strategies
17.4 F. Hoffmann-La Roche Ltd. (Switzerland)
17.4.1 Overview
17.4.1 Overview
17.4.2 Offerings
17.4.3 Key Financials
17.4.4 Business Segment & Geographic Overview
17.4.5 Key Market Developments
17.4.6 Key Strategies
17.5 Johnson & Johnson Private Limited (U.S.)
17.5.1 Overview
17.5.2 Offerings
17.5.3 Key Financials
17.5.4 Business Segment & Geographic Overview
17.5.5 Key Market Developments
17.5.6 Key Strategies
17.6 Novartis AG (Switzerland)
17.6.1 Overview
17.6.2 Offerings
17.6.3 Key Financials
17.6.4 Business Segment & Geographic Overview
17.6.5 Key Market Developments
17.6.6 Key Strategies
17.7 Alnylam Pharmaceuticals, Inc. (U.S.)
17.7.1 Overview
17.7.2 Offerings
17.7.3 Key Financials
17.7.4 Business Segment & Geographic Overview
17.7.5 Key Market Developments
17.7.6 Key Strategies
17.8 Pfizer Inc. (U.S.)
17.8.1 Overview
17.8.2 Offerings
17.8.3 Key Financials
17.8.4 Business Segment & Geographic Overview
17.8.5 Key Market Developments
17.8.6 Key Strategies
17.9 AstraZeneca (U.K.)
17.9.1 Overview
17.9.2 Offerings
17.9.3 Key Financials
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies
17.10 Mylan N.V. (U.S.)
17.10.1 Overview
17.10.2 Offerings
17.10.3 Key Financials
17.10.4 Business Segment & Geographic Overview
17.10.5 Key Market Developments
17.10.6 Key Strategies
17.11 Teva Pharmaceutical Industries Ltd. (Israel)
17.11.1 Overview
17.11.2 Offerings
17.11.3 Key Financials
17.11.4 Business Segment & Geographic Overview
17.11.5 Key Market Developments
17.11.6 Key Strategies
17.12 Sun Pharmaceutical Industries Ltd. (India)
17.12.1 Overview
17.12.2 Offerings
17.12.3 Key Financials
17.12.4 Business Segment & Geographic Overview
17.12.5 Key Market Developments
17.12.6 Key Strategies
Inquire Before Buying Request Free Sample Ask For Discount